Cencora's (NYSE:COR) Earnings Growth Rate Lags the 23% CAGR Delivered to Shareholders
Moderna Remains the Most Shorted Among S&P 500 Healthcare Stocks in November
Cencora Is Maintained at Equal-Weight by Wells Fargo
Cencora Analyst Ratings
Wells Fargo Maintains Cencora(COR.US) With Hold Rating, Cuts Target Price to $237
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
(COR) - Analyzing Cencora's Short Interest
Cencora's Strategic Acquisition and Financial Maneuvering
Cencora Closes $1.8 Billion Senior Notes Offering
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Cencora (COR) Slid on Uneven Fiscal Third Quarter Results
Baird Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $302
Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
Express News | Cencora : Baird Raises Target Price to $302 From $292
BofA Securities Maintains Cencora(COR.US) With Hold Rating, Raises Target Price to $260
Cencora's Strategic Innovations Enhance Supply Chain Amidst Neutral Market Valuation
There May Be Some Bright Spots In Cencora's (NYSE:COR) Earnings
Express News | Outlook Therapeutics Inc - Enters Strategic Collaboration With Cencora
Express News | Cencora : Mizuho Assumes Coverage With Outperform Rating; Price Target $280
Possible Bearish Signals With Cencora Insiders Disposing Stock